無針ドラッグデリバリーデバイス市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPHE100001168
  • Category : Medical Device
  • Status : Data Released
  • No. of Pages : 150
Buy Now

市場概要

無針薬物送達システムは、薬物やその他の種類の医薬品を送達する革新的な方法です。それらはまた、経皮パッチ、吸入システム、さらには従来の針のように皮膚を刺さないマイクロニードルの形態であってもよい。 1 型糖尿病患者は定期的な血糖値のモニタリングが必要で、インスリン投与に針を使用するため、感染症や痛みのリスクが高まります。針のないデバイスにより、痛みの少ない出産が可能になり、感染のリスクが軽減されます。その結果、これらのデバイスの需要は、予測期間中に増加すると予想されます。

市場範囲

「2028 年までの世界の無針薬物送達デバイス市場分析」は、2028 年までの世界の無針薬物送達デバイス市場の専門的かつ詳細な調査です。世界市場のトレンド分析に特に焦点を当てた食品および飲料業界。このレポートは、技術、アプリケーション、および地域ごとの詳細な市場分割とともに、無針薬物送達デバイス市場の概要を提供することを目的としています。このレポートは、無針ドラッグデリバリーデバイス市場の主要プレーヤーの市場状況に関する重要な統計を提供し、市場の主要な傾向と機会を提供します。

市場セグメンテーション

    • 技術に基づいて、世界のニードルフリードラッグデリバリーデバイス市場は、吸入器、経皮パッチ、ジェットインジェクター、新規ニードルフリーに分類されます。 • アプリケーションに基づいて、市場は小児用注射、インスリン送達デバイス、ワクチン送達デバイス、その他に分割されます。

市場力学

要因

    • 糖尿病と慢性疾患の有病率の増加。 • 無痛で薬剤を投与する需要が高まっています。 • ドラッグデリバリーデバイスの技術進歩。

拘束

    • これらのデバイスは高価であり、厳格な規制承認プロセスが必要です。

地域的枠組み

このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2019 年から 2028 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南米。各地域別の無針薬物送達デバイス市場は、後でそれぞれの国とセグメントごとにサブセグメント化されます。このレポートでは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会について取り上げています。レポートは、需要と供給の両方の側面から市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場のダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、南米は、これらの地域の無針薬物送達デバイス市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。

無針薬物送達デバイス市場に対する新型コロナウイルス感染症 (COVID-19) の影響

現在、世界中で複数の新型コロナウイルス 19 ワクチン開発プログラムが実施されています。うまくいけば、これらのいくつかは間もなく使用が承認され、大きな影響を与えるでしょう。並行して、このようなワクチンを国規模および世界規模で配布および投与するための適切な能力を構築するために、政府および非営利団体によって多額の投資が行われています。無針薬物送達デバイスはリスクがなく、安全で効果的であるため、ワクチン投与用の需要が増加すると予想されます。たとえば、2020年10月に米国FDAは、PharmaJetが新型コロナウイルス感染症ワクチン候補試験用に開発した無針注射システムに510(k)の販売許可を与えた。

市場関係者

このレポートでは、有機的および無機的な成長戦略として、無針ドラッグデリバリーデバイス市場の主要な発展について取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略活動は、買収、パートナーシップとコラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。無針ドラッグデリバリーデバイス市場の支払者は、世界市場での無針ドラッグデリバリーデバイスの需要の高まりにより、将来的に有利な成長機会が期待されています。レポートには、無針薬物送達デバイス市場における主要企業のSWOT分析と市場戦略とともにプロフィールも含まれています。さらに、このレポートは業界の主要企業に焦点を当てており、企業概要、提供されるコンポーネント、サービス、過去 3 年間の財務情報、過去 5 年間の主要な開発などの情報を提供します。
    • アンタレス ファーマ株式会社 • エンドーインターナショナル株式会社• ファーマジェット •  Bioject Medical Technologies Inc. •  Medical International Technology, Inc. • インジェックス ファーマ AG •  National Medical Products Inc. • ヴァレリタス株式会社 •  European Pharma Group •  PenJet Corporation
Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供します。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is needle-free drug delivery device?

Needle-free drug deliveries are taken in the form of power sprays, jet injectors, inhalers, and skin patches. Needle-free technology reduces patient concern about using needles. Needle-free devices are effective injections for a wide range of drugs and are bioequivalent to needles. Advantages of needle-free delivery devices include less pain, fast injection, no needle disposal issue, and can be self-administered. Thus, the benefits of needle-free drug delivery devices over conventional needles and syringes are mainly responsible for the increasing demand for needle-free drug delivery devices.

What are the driving and restraining factors for the needle-free drug delivery device market?

Increasing prevalence of chronic diseases and increasing needlestick injuries propels the needle-free drug delivery devices market growth. However, the high cost of development as compare to injections hinders the growth of the market.

Who are the major players in market the needle-free drug delivery device market?

The needle-free drug delivery device market majorly consists of the players such NuGen Medical Devices Inc, NovaXS Biotech, GlaxoSmithKline, AstraZeneca, Roche, Boehringer Ingelheim, Merck, Cipla, Novartis, Teva Pharmaceuticals, Omron Healthcare, Sumitomo Pharma Co., Ltd

Which segment is dominating the needle-free drug delivery device market?

Based on type, the needle-free drug delivery devices market is segmented into inhalers, jet injectors, novel needles, transdermal patches, and others.
By application, the market is segmented into insulin delivery, vaccination, pain management, and others. The insulin delivery disease segment dominated the market in 2023.

Which region is dominating the needle-free drug delivery device market?

Based on geography, the needle-free drug delivery device market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global needle-free drug delivery device market. Asia Pacific is expected to register the highest CAGR in the needle-free drug delivery device market during 2022–2030.

The List of Companies - Needle-Free Drug Delivery Devices Market 

  1. NuGen Medical Devices Inc
  2. NovaXS Biotech
  3. GlaxoSmithKline
  4. AstraZeneca
  5. Roche
  6. Boehringer Ingelheim
  7. Merck
  8. Cipla
  9. Novartis
  10. Teva Pharmaceuticals
  11. Omron Healthcare
  12. Sumitomo Pharma Co., Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports